-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-surgery-preparation_disposition-comments.pdf
April 30, 2014 - TEP #1 Executive
Summary
ES-3 Line 48: I vaguely remember discussing venous
thromboembolism in our … Are there data indicating that
OMBPmight or might not be a risk factor for VTE? … The issue of VTE was discussed (in varying levels
of details) in each of the TEP teleconferences we … We decided to include VTE (DVT and PE)
outcomes in our review, however the available
evidence was limited … prolong hospitalization or slow the
rate of recovery post-surgery, and in that way
increase the risk of VTE
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
April 01, 2012 - Effects of random
allocation to vitamin E supplementation on the occurrence of
venous thromboembolism
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_executive.pdf
January 01, 2020 - moderate-strength evidence
that HPV vaccine is not associated with appendicitis,
stroke, seizures, syncope, venous … thromboembolism, onset
of juvenile arthritis, or onset of type 1 diabetes and high-
strength evidence
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rti-item-bank-bias-precision_research.pdf
September 01, 2011 - Prevention of Venous Thromboembolism
After Injury. Evidence Report/ Technology
Assessment No. 22.
-
effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_2.pdf
May 01, 2020 - However, there is a tradeoff, since cesarean delivery
itself increases the risk of maternal hemorrhage,
venous … thromboembolism, and injury to the
bladder and other internal organs, and can
affect post-delivery
-
effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_executive.pdf
February 01, 2016 - 1
Comparative Effectiveness Review
Number 167
Management of Renal Masses
and Localized Renal Cancer
Executive Summary
Background
Renal masses are a biologically
heterogeneous group of tumors
ranging from benign masses to cancers
that can be indolent or aggressive.1,2
The true incidence of renal masses
(in…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - Comparative Effectiveness Review
118
Appendix A. Pharmacokinetics, Indications and
Dosing of Included Drugs
Drug and Trade
Name
(Trade names
provided only for
drugs under
patent.)
Half-life or other
relevant
pharmacokinetic
feature
Labeled indications Dosing (oral
doses)
Dose adjustments fo…